Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome

American Journal of Pathology

Volumn 152, Issue 3, 1998, Pages 651-657

  Adawi, Adnan ^a,b   Zhang, Ying ^a   Baggs, Raymond ^b   Finkelstein, Jacob ^a,b   Phipps, Richard P ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GLYCOPROTEIN GP 39; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MR 1; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HYPEROXIA; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG INJURY; MALE; MOUSE; NONHUMAN; OXYGEN THERAPY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; CD40 LIGAND; CRICETINAE; DISEASE MODELS, ANIMAL; HUMANS; HYPEROXIA; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; LIGANDS; LUNG DISEASES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; OXYGEN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0031912791     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jackson RM: Pulmonary oxygen toxicity. Chest 1985, 88:900-905
2. Fulkerson W. MacIntyre N, Stamler J, Crapo J: Pathogenesis and treatment of the adult respiratory distress syndrome. Arch Intern Med 1996, 156:29-38
3. Tsan U, White J, Michelson PB, Wong GH: Pulmonary oxygen toxicity: role of endogenous TNF. Exp Lung Res 1995, 21:589-597
4. Noelle RJ, Ledbetter J A, Aruffo A: CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 1992, 13:431-433
5. Banchereau J, Bazan F, Blanchard D, Brier F, Galizzi J, Van Kooten C, Liu Y, Roussel F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 1994, 12:881-922
6. Noelle RJ: CD40 and its ligand in host defense. Immunity 1996, 4:415-419
7. Alderson M, Armitage R, Tough T, Stockbine L, Fanslow W, Spriggs M: CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993, 178:669-674
8. Fries K, Gaspari A, Blieden T, Looney RJ, Phipps RP: CD40 expression by human fibroblasts. Clin Immunol Immunopathol 1995, 77:42-51
9. Gaspari A, Sempowski G, Chess P, Gish J, Phipps RP: Human epidermal keratinocytes are induced to secrete IL-6 and costimulate T cell proliferation by a CD40-dependent mechanism. Eur J Immunol 1996, 26:1371-1377
10. Hollenbaugh D, Petty N, Edwards C, Simon J, Denfield R, Kiener P Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995, 182:33-40
11. Sempowski G, Chess P, Moretti A, Padilla J, Linares A, Phipps RP, Blieden T: Expression and significance of CD40 on human periodontal fibroblasts. J Periodontol 1996, 68:284-292
12. Sempowski G, Chess P, Phipps RP: CD40 is a functional activation antigen and major T cell costimulatory molecule on normal human lung fibroblasts. J Immunol 1997, 158:4670-4677
13. Durie F, Fava R, Foy A, Aruffo A, Ledbetter J, Noelle R: Prevention of collagen induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993, 261:1328-1330
14. Gerritse K, Laman J, Noelle R, Aruffo A, Ledbetter J, Boersma W, Classen E: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1996, 93:2499-2504
15. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 1997, 158:29-39
16. Adamson YR: Oxygen poisoning in mice: ultrastructural and surfactant studies during exposure and recovery. Arch Pathol 1970, 90: 463-472
17. Smith LJ: Hyperoxic lung injury: biochemical, cellular, and morphologic characterization in the mouse. J Lab Clin Med 1985, 106:269-278
18. Noelle R, Roy M, Sheperd D, Stamenkovic I, Ledbetter J, Aruffo A: A 39-kd protein on activated T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992, 89:6550-6559
19. Hildreth S, Baggs R, Brownstein D, Castleman W, Paradiso P: Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization. Vaccine 1993, 11:615-618
20. Vigano T, Tola A, Crivellari M, Galli D, Mezzetti M, Folco G: Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma. Eicosanoids 1988, 1:73-77
21. Mitchell J, Akarasereenont P, Thierermann C, Flower R, Vane JR: Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994, 90:11693-11697
22. Wu KK: Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles. J Lab Clin Med 1996, 128:242-245
23. Grimminger F, Kurten I, Walmrath D, Seeger W: Type II alveolar epithelial eicosanoid metabolism: predominance of Cox pathways and transcellular lipoxygenase metabolism in co-culture with neutrophils. Am J Respir Cell Mol Biol 1992, 6:9-16
24. Smith RS, Smith TJ, Blieden TM, Phipps RP: Fibroblasts as sentinel cells: synthesis of chemokines and regulation of inflammation. Am J Pathol 1997, 151:317-321
25. Maier J, Hla T, Maciag T: Cyclooxygenase is an immediate early gene induced by interleukin 1 in human endothelial cells. J Biol Chem 1990, 265:10805-10808